GH Research PLC (GHRS)
11.68
+0.49
(+4.38%)
USD |
NASDAQ |
May 03, 16:00
11.73
+0.05
(+0.43%)
After-Hours: 20:00
GH Research 1 Year Total Returns (Daily): 37.41% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | 37.41% |
May 02, 2024 | 25.45% |
May 01, 2024 | 32.78% |
April 30, 2024 | 30.48% |
April 29, 2024 | 27.98% |
April 26, 2024 | 31.87% |
April 25, 2024 | 32.91% |
April 24, 2024 | 35.78% |
April 23, 2024 | 42.14% |
April 22, 2024 | 47.42% |
April 19, 2024 | 31.31% |
April 18, 2024 | 32.74% |
April 17, 2024 | 31.77% |
April 16, 2024 | 36.35% |
April 15, 2024 | 45.41% |
April 12, 2024 | 31.65% |
April 11, 2024 | 36.14% |
April 10, 2024 | 31.86% |
April 09, 2024 | 29.71% |
April 08, 2024 | 29.36% |
April 05, 2024 | 34.22% |
April 04, 2024 | 39.14% |
April 03, 2024 | 39.47% |
April 02, 2024 | 38.17% |
April 01, 2024 | 38.67% |
Date | Value |
---|---|
March 28, 2024 | 42.32% |
March 27, 2024 | 40.92% |
March 26, 2024 | 39.85% |
March 25, 2024 | 33.04% |
March 22, 2024 | 78.90% |
March 21, 2024 | 68.10% |
March 20, 2024 | 58.27% |
March 19, 2024 | 41.06% |
March 18, 2024 | 40.03% |
March 15, 2024 | 30.07% |
March 14, 2024 | 17.57% |
March 13, 2024 | 18.12% |
March 12, 2024 | 6.81% |
March 11, 2024 | -3.46% |
March 08, 2024 | -18.90% |
March 07, 2024 | -20.58% |
March 06, 2024 | -22.53% |
March 05, 2024 | -19.12% |
March 04, 2024 | -22.65% |
March 01, 2024 | -18.27% |
February 29, 2024 | -7.31% |
February 28, 2024 | -14.09% |
February 27, 2024 | -8.50% |
February 26, 2024 | -16.27% |
February 23, 2024 | -21.71% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-66.31%
Minimum
Mar 22 2023
78.90%
Maximum
Mar 22 2024
-25.41%
Average
-33.69%
Median
Aug 25 2023
1 Year Total Returns (Daily) Benchmarks
Amarin Corp PLC | -33.09% |
Jazz Pharmaceuticals PLC | -19.48% |
Prothena Corp PLC | -65.81% |
Iterum Therapeutics PLC | 37.17% |
Mural Oncology PLC | -- |